Article info
PDFOriginal article
Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma
- Correspondence to Xiongzeng Zhu, Department of Pathology, Cancer Hospital, Fudan University, 270 Dongan Road, Shanghai 200032,China; xiongzengzhu{at}yahoo.com.cn
Citation
Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma
Publication history
- Accepted May 5, 2010
- First published July 19, 2010.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.